Page last updated: 2024-11-04

rolipram and Leukemia, Myeloid, Acute

rolipram has been researched along with Leukemia, Myeloid, Acute in 2 studies

Leukemia, Myeloid, Acute: Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Copsel, S2
Bruzzone, A1
May, M1
Beyrath, J1
Wargon, V1
Cany, J1
Russel, FG2
Shayo, C2
Davio, C2
Garcia, C1
Diez, F1
Vermeulem, M1
Baldi, A1
Bianciotti, LG1

Other Studies

2 other studies available for rolipram and Leukemia, Myeloid, Acute

ArticleYear
Multidrug resistance protein 4/ ATP binding cassette transporter 4: a new potential therapeutic target for acute myeloid leukemia.
    Oncotarget, 2014, Oct-15, Volume: 5, Issue:19

    Topics: Animals; Apoptosis; Cell Cycle Checkpoints; Cell Differentiation; Cell Line, Tumor; Cell Proliferati

2014
Multidrug resistance protein 4 (MRP4/ABCC4) regulates cAMP cellular levels and controls human leukemia cell proliferation and differentiation.
    The Journal of biological chemistry, 2011, Mar-04, Volume: 286, Issue:9

    Topics: Cell Differentiation; Cell Division; Cyclic AMP; Drug Design; HL-60 Cells; Humans; Leukemia, Myeloid

2011